News

Genome-wide analysis now also possible for intended parents with a new genetic disorder

31 August 2021

At UZ Leuven it is now possible for intended parents to screen an embryo for a genetic disorder that did not previously occur in the family with one single test. Researchers at the Leuven centre for human genetics developed an all-in-one test for monitor embryos for a de novo genetic disorder.

Plasma with antibodies does not result in a better outcome for COVID-19-patients

27 August 2021

The national DAWn-plasma trial examined whether plasma, donated by convalescent COVID-19-patients, could improve the outcome for new patients. It did not have the expected positive effect: patients treated with convalescent plasma had the same need for mechanical ventilation and a similar mortality rate.

Preventive radiotherapy makes high-risk prostate cancer more curable

25 August 2021

For prostate cancer patients with a high risk of of lymph node metastases in the pelvis, preventive radiation therapy of these lymph nodes will increase the chance of being definitely cured. A multidisciplinary UZ Leuven team led an international trial.

Transplantoux cycles from the Gasthuisberg campus to Milan

23 August 2021

On Monday morning 23 August a Transplantoux peloton started a bike ride to Milan. In five days' time they will cycle to the main European transplantation congress. In the boot of the support car: a melting block of ice.

Estimating patient size based on X-ray images improves accuracy of the radiation dose

18 August 2021

The size of a patient determines the amount of radiation required for a successful X-ray examination. A new measuring method allow professor medical radiation physics Hilde Bosmans and her team to determine a more accurate radiation dose.

New genetic anomaly and therapeutic target discovered in rare lymphoma

13 August 2021

UZ Leuven and KU Leuven researchers have discovered a new genetic anomaly which lies at the root of a rare lymphoma. The discovery opens up new perspectives for a better treatment.

Patient monitoring: current situation

11 August 2021

Five years ago 5 European hospitals started developing a sensor to monitor patients in a streamlined way both during their hospital admission and at home. The sensor will be presented on 16 September 2021 at an international symposium on patient monitoring and wearable sensors.

Supplement with probiotics can alleviate unexplained stomach complaints

4 August 2021

Food supplements with beneficial bacteria or probiotics can reduce unexplained stomach complaints, presumably by improving the gut flora and by positively influencing the immune system, as shown for the first time by a trial led by UZ Leuven in 68 patients.

UZ Leuven gets to work with the FlaQuM quality model

9 July 2021

In 2019 UZ Leuven was awarded the JCI quality label for the fourth time running. This accreditation is valid until 2023. There will not be a fifth JCI audit. UZ Leuven has decided to get to work with the new Flemish quality model for healthcare organisations, FlaQuM.

Government study researches civilian help for first aid in Belgium

1 July 2021

Civilian help for first aid in case of heart attacks or stroke in neighbouring countries as the Netherlands & Germany for much higher survival rates dan in ons land. Commissioned by the government, emergency doctors at UZ Leuven are now researching how the system of medical first responders can be applied in Belgium.

Vesalius project gives new meaning to pathology institute and anatomical theatre

21 June 2021

In 2025, KU Leuven and UZ Leuven will be opening a new public experience centre on the Hertogen site in Leuven. The Vesalius project will be dedicated to scientific research, care and society. The university will be restoring two historic buildings to house the project.

Inflammation of the duodenum seems to be cause of unexplained stomach problems

16 June 2021

Leuven researchers have discovered that stomach problems are often linked to an inflamation of the first part of the small intestine. The degree of inflammation is considered to be a new biomarker that can help reach the right diagnosis. At the same time it is an important starting point for better treatments.